Google AI Mode Conversation: Non-Verbal Cognitive Tasks for Depression & Pre-Clinical Drug Screening

Query

“best cognitive task for identifying depression”

Full Conversation

To cross the barrier of language and age, researchers and clinicians use language-independent behavioral assays. Because they do not rely on reading or speaking, these exact same tasks can be applied to young children, rodents, primates, and human adults. [1]

These non-verbal cognitive tasks isolate “hot” affective biases (how mood alters choices) and “cold” executive controls to identify depression-like states. [2, 3]

1. The Affective Bias Test (ABT)

The Affective Bias Test (ABT) is the gold standard for measuring how a depressed state alters learning and memory. It is fully translationally validated for both animals (rodents) and young children. [2, 4, 5]

Mechanism: The subject encounters two different neutral, non-verbal cues on different days (e.g., two different digging textures for an animal, or two different abstract colored shapes on a screen for a child). Both cues yield the exact same positive reward (a treat or a game token). However, one cue is learned while the subject is in a normal state, and the other is learned under a localized negative or stressed state. Later, the subject is given a free choice between the two cues. [5, 6, 7]

Depression Marker: Depressed individuals exhibit a severe negative affective bias. Even though both options yield the exact same physical reward, they heavily avoid the cue associated with the period of negative mood, showing that depression actively distorts memory consolidation and value tracking. [2, 5, 6, 8, 9]

2. Ambiguity-Judgement / Cognitive Bias Task

This task tests the “glass half empty” phenomenon entirely through non-verbal audio tones or visual prompts.

Mechanism: The subject is trained to understand two extremes: a high-pitched tone means “press a button to get a reward,” and a low-pitched tone means “don’t press, or you will get a mild punishment” (like a time-out or an annoying buzzer). Once trained, researchers introduce an ambiguous, perfectly mid-pitched tone. [10, 11]

Depression Marker: Healthy children and animals display an “optimistic” bias and press the button, anticipating a reward. Depressed subjects show a distinct “pessimistic” bias. They interpret the ambiguous tone as a threat or failure and refuse to act, mirroring the lack of motivation and fear of negative outcomes seen in clinical depression. [2, 12]

3. Spatial Delayed Match-to-Sample (DMS)

Administered via non-verbal, touchscreen-based platforms like the Cambridge Neuropsychological Test Automated Battery (CANTAB), this task evaluates short-term visual memory and pattern recognition without words. [13]

Mechanism: The child or animal is shown a complex, non-verbal abstract geometric pattern on a screen. The pattern vanishes. After a short delay (ranging from 0 to 12 seconds), a choice of four patterns appears. The subject must touch the pattern that matches the original stimulus. [13]

Depression Marker: Depressed subjects show a profound drop-off in performance as the delay time increases. This flags a breakdown in visual working memory and neuroplasticity, which are heavily degraded by prolonged stress and depression. [13, 14, 15, 16, 17]

4. Non-Verbal Intradimensional / Extradimensional (ID/ED) Shift

This task measures cognitive flexibility and frontostriatal brain function, testing how well a subject adapts when the rules of the world change.

Mechanism: The subject is presented with visual shapes on a screen and learns by trial-and-error to select the correct shape to receive a reward. Once they master this rule, the criteria changes (e.g., the reward is no longer based on the shape, but on the color).

Depression Marker: Depressed children and animals display severe perseveration—they will continuously touch the old, incorrect choice over and over again. Their brains struggle to flexibly update behavior when environmental contingencies shift, a core cognitive deficit in major depressive disorder. [18]

Summary of Non-Verbal Indicators

Non-Verbal Task [1, 4, 5, 13, 19]	Cognitive Metric	Animal Protocol	Child Protocol
Affective Bias Test	Biased memory retrieval	Digging bowl textures	Card/Object pairing
Cognitive Bias Task	Pessimism vs. Optimism	Tone pitches & food	Tone pitches & touchscreens
Delayed Match-to-Sample	Visual working memory	Primate screen selection	Kids touchscreen matching
ID/ED Shift Task	Mental flexibility	Odor/Texture discrimination	Color/Shape discrimination

Pre-Clinical Drug Screening Study Design

The standard experimental architecture for testing a new chemical entity (NCE) requires careful planning of model induction, selection of translationally validated tasks, and tracking of specific performance metrics.

Step 1: Establish the Disease Model (Phenotype Induction)

Before screening a drug, one must induce a valid depression-like state in rodent cohorts:

• Chronic Unpredictable Mild Stress (CUMS): Shifting environmental stressors over 4-6 weeks replicates gradual environmental onset.
• Social Defeat Stress (SDS): Social avoidance and anhedonia phenotype.
• Pharmacological Inducers: Tetrabenazine (monoamine depletion) or systemic LPS (neuroinflammation).

Step 2: Select Primary Screening Tasks

• Task A: Affective Bias Test (ABT) — bowl-digging or touchscreen assay evaluating how a drug modifies emotional memory encoding/retrieval. Depressed controls avoid the negatively-associated substrate. Effective antidepressants (ketamine, psilocybin) attenuate the negative memory bias.
• Task B: Cognitive Judgement Bias (CJB) / Pessimism Task — operant box task. Rapid-acting antidepressants (ketamine) alter judgment instantly; conventional SSRIs (fluoxetine) reverse bias only after chronic 2-3 week administration.

Step 3: Treatment Cohorts

Four core parallel tracks: Vehicle Control (healthy baseline), Drug Control (safety), Depressed + Vehicle (disease model), Depressed + Reference Drug (ketamine/fluoxetine), Depressed + Candidate Drug (experimental arm).

Step 4: Key Metrics

• Choice Bias Ratio: Positive Choice Responses / Total Responses
• Omission Rates: Distinguish cognitive-affective recovery from sedation
• Locomotor Activity Control: Open field test to rule out psychostimulant confound
• Sustained vs. Acute Clearance: Test at 1-hour (acute) and 24-hour (sustained) post-dose

References

[1] Cambridge Cognition — https://cambridgecognition.com/cognitive-assessment-throughout-development/ [2] PubMed 27660073 — https://pubmed.ncbi.nlm.nih.gov/27660073/ [3] Roiser — Affective Biases in Humans and Animals — https://discovery.ucl.ac.uk/1525527/1/Roiser_Affective%20Biases%20in%20Humans%20and%20Animals_AAM.pdf [4] PubMed 38923877 — https://pubmed.ncbi.nlm.nih.gov/38923877/ [5] EPA HERO — https://hero.epa.gov/reference/10664559/ [6] Glasgow eprints — https://eprints.gla.ac.uk/319725/1/319725.pdf [7] Dr Adam Volungis — https://dradamvolungis.com/classes/psy-501/class-discussion-psy-501/topic-2-behavioral-approach-by-930/ [8] Current Protocols — https://currentprotocols.onlinelibrary.wiley.com/doi/full/10.1002/cpz1.1057 [9] Frontiers — https://www.frontiersin.org/research-topics/73962/intelligent-sensing-for-mental-health-ai-and-unobtrusive-wearables-in-diagnosing-and-intervening-in-depression-and-cognitive-disorders [10] PMC 9334413 — https://pmc.ncbi.nlm.nih.gov/articles/PMC9334413/ [11] Brill — https://brill.com/view/journals/beh/158/14-15/article-p1303_5.xml [12] PMC 4199314 — https://pmc.ncbi.nlm.nih.gov/articles/PMC4199314/ [13] Cambridge Cognition — https://cambridgecognition.com/6-cognitive-tests-for-research-of-depression-and-mood-disorders/ [14] ScienceDirect — https://www.sciencedirect.com/science/article/pii/S0278584625000557 [15] Science Translational Medicine — https://www.science.org/doi/10.1126/scitranslmed.adi2403 [16] ISCA Archive — https://www.isca-archive.org/smm_2024/vassover24_smm.pdf [17] PMC 11720972 — https://pmc.ncbi.nlm.nih.gov/articles/PMC11720972/ [18] PMC 7047599 — https://pmc.ncbi.nlm.nih.gov/articles/PMC7047599/ [19] PubMed 35472473 — https://pubmed.ncbi.nlm.nih.gov/35472473/